TE_53

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family AluSz, SVA_E
TE superfamily Alu, SVA
TE class Retroposon, SINE
Gene RPL22
Class Chimeric
Coding Non-coding
Tumor-specific score 1.23
Counts of samples TCGA_tumor:99; TCGA_normal:5; GTEx:86
TSS chr1(-):6202693



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_53.1 RPL22 Chimeric Non-coding Non-coding chr1(-):6193034,6193054,6197652,6197756,6200489,6200750,6202631,6202694
teRNA_53.2 RPL22 Chimeric Non-coding Non-coding chr1(-):6186796,6186816,6192930,6193054,6197652,6197756,6200489,6200832,6202631,6202694
teRNA_53.3 RPL22 Chimeric Non-coding Non-coding chr1(-):6193034,6193054,6197652,6197756,6200489,6200832,6202631,6202694
teRNA_53.4 RPL22 Chimeric Non-coding Non-coding chr1(-):6193034,6193054,6197652,6197756,6200489,6200727,6202631,6202694


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).